相似文献
1
Predictors of cost-effectiveness of selected COPD treatments in primary care: UNLOCK study protocol.
NPJ Prim Care Respir Med. 2015 Aug 6;25:15051. doi: 10.1038/npjpcrm.2015.51.
2
[Costs of chronic obstructive pulmonary disease in patients treated in ambulatory care in Poland].
Pneumonol Alergol Pol. 2011;79(5):337-42.
3
[Costs of exacerbations of chronic obstructive pulmonary disease in primary and secondary care in 2007--results of multicenter Polish study].
Pol Merkur Lekarski. 2009 Mar;26(153):208-14.
4
Burden of chronic obstructive pulmonary disease in Medicare beneficiaries residing in long-term care facilities.
Am J Geriatr Pharmacother. 2009 Oct;7(5):262-70. doi: 10.1016/j.amjopharm.2009.11.003.
5
Costs of chronic obstructive pulmonary disease in relation to compliance with guidelines: a study in the primary care setting.
Ther Adv Respir Dis. 2013 Jun;7(3):139-50. doi: 10.1177/1753465813484080. Epub 2013 May 7.
6
Improvement in COPD management by access to asthma/COPD clinics in primary care: data from the observational PATHOS study.
Respir Med. 2014 Sep;108(9):1345-54. doi: 10.1016/j.rmed.2014.06.002. Epub 2014 Jun 17.
7
Determinants and predictors of the cost of COPD in primary care: a Spanish perspective.
Int J Chron Obstruct Pulmon Dis. 2008;3(4):701-12. doi: 10.2147/copd.s2427.
8
Cost analysis of chronic obstructive pulmonary disease in a tertiary care setting in Taiwan.
Respirology. 2008 Sep;13(5):689-94. doi: 10.1111/j.1440-1843.2008.01308.x. Epub 2008 May 29.
9
Costs of COPD exacerbations in the emergency department and inpatient setting.
Respir Med. 2011 Mar;105(3):454-60. doi: 10.1016/j.rmed.2010.09.003.
10
Risk of hospitalizations/emergency department visits and treatment costs associated with initial maintenance therapy using fluticasone propionate 500 microg/salmeterol 50 microg compared with ipratropium for chronic obstructive pulmonary disease in older adults.
Am J Geriatr Pharmacother. 2008 Aug;6(3):138-46. doi: 10.1016/j.amjopharm.2008.08.005.
引用本文的文献
1
Work absence in patients with asthma and/or COPD: a population-based study.
NPJ Prim Care Respir Med. 2021 Feb 16;31(1):9. doi: 10.1038/s41533-021-00217-z.
2
[Association between the use of short-acting bronchodilators and the risk of hospitalization for asthma in a real-life clinical practice population cohort].
Aten Primaria. 2020 Nov;52(9):600-607. doi: 10.1016/j.aprim.2020.03.004. Epub 2020 Jun 20.
3
Prevalence of Seasonal Influenza Vaccination in Chronic Obstructive Pulmonary Disease (COPD) Patients in the Balearic Islands (Spain) and Its Effect on COPD Exacerbations: A Population-Based Retrospective Cohort Study.
Int J Environ Res Public Health. 2020 Jun 5;17(11):4027. doi: 10.3390/ijerph17114027.
4
Identifying individuals with physician-diagnosed chronic obstructive pulmonary disease in primary care electronic medical records: a retrospective chart abstraction study.
NPJ Prim Care Respir Med. 2017 May 15;27(1):34. doi: 10.1038/s41533-017-0035-9.
5
Randomized controlled trials and real-world observational studies in evaluating cardiovascular safety of inhaled bronchodilator therapy in COPD.
Int J Chron Obstruct Pulmon Dis. 2016 Nov 25;11:2885-2895. doi: 10.2147/COPD.S118867. eCollection 2016.
本文引用的文献
1
Primary care COPD patients compared with large pharmaceutically-sponsored COPD studies: an UNLOCK validation study.
PLoS One. 2014 Mar 5;9(3):e90145. doi: 10.1371/journal.pone.0090145. eCollection 2014.
2
Asthma care practicing among general practitioners in Lebanon: a cross-sectional study.
J Asthma. 2014 Feb;51(1):51-7. doi: 10.3109/02770903.2013.843096. Epub 2013 Oct 8.
3
Variability of hospital resources for acute care of COPD patients: the European COPD Audit.
Eur Respir J. 2014 Mar;43(3):754-62. doi: 10.1183/09031936.00074413. Epub 2013 Aug 29.
4
COPD in the working age population: the economic impact on both patients and government.
COPD. 2013 Dec;10(6):629-39. doi: 10.3109/15412555.2013.813446. Epub 2013 Jul 11.
5
Costs of chronic obstructive pulmonary disease in relation to compliance with guidelines: a study in the primary care setting.
Ther Adv Respir Dis. 2013 Jun;7(3):139-50. doi: 10.1177/1753465813484080. Epub 2013 May 7.
6
Guideline adherence in management of stable chronic obstructive pulmonary disease.
Respir Med. 2013 Jul;107(7):1046-52. doi: 10.1016/j.rmed.2013.04.001. Epub 2013 Apr 30.
7
Factors associated with high healthcare resource utilisation among COPD patients.
Respir Med. 2012 Dec;106(12):1734-42. doi: 10.1016/j.rmed.2012.09.009. Epub 2012 Oct 9.
8
Clinical audit of COPD patients requiring hospital admissions in Spain: AUDIPOC study.
PLoS One. 2012;7(7):e42156. doi: 10.1371/journal.pone.0042156. Epub 2012 Jul 31.
9
Barriers to adherence to COPD guidelines among primary care providers.
Respir Med. 2012 Mar;106(3):374-81. doi: 10.1016/j.rmed.2011.09.010. Epub 2011 Oct 13.
10
Inappropriate overuse of inhaled corticosteroids for COPD patients: impact on health costs and health status.
Lung. 2011 Jun;189(3):199-206. doi: 10.1007/s00408-011-9289-0. Epub 2011 Apr 17.
Zotero 插件